-
Results of this small pilot trial suggest that a specialized movement program based on the principles of Feldenkrais therapy, when offered to elderly community-dwelling subjects twice weekly for 10 weeks, improves objective measures of balance and movement as well as self-confidence in both areas.
-
In the 2007 national health interview survey (NHIS), approximately 38% of adults reported using complementary and alternative medicine (CAM) in the previous 12 months.
-
A randomized controlled trial demonstrated that "perfect" empathy with patients results in a better immune response, reduction of symptoms, and faster recovery from a common cold.
-
Red yeast rice and therapeutic lifestyle changes decrease LDL-cholesterol levels without increasing CPK or pain levels and may be a treatment option for dyslipidemic patients who cannot tolerate statin therapy.
-
A study group in Greece used 3 consecutive different regimens to achieve a 98% eradication rate among 540 patients not lost to follow-up. The success of each individual regimen was about 70%.
-
A new antiplatelet drug has been approved by the FDA for patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention.
-
Hidradenitis suppurativa (HSP) is regarded both in the dermatology and primary care communities as a "heart sink" diagnosis: Patients are generally chronically burdened, we have little successful treatment, the pathophysiology is poorly understood, and the consequences often have an important negative impact on quality of life.
-
-
Polypharmacy is the simultaneous use of multiple medications. Many authors have defined polypharmacy as the simultaneous use of at least five or six medications. Others have suggested that polypharmacy should not be determined by the absolute number of medications, but rather the use of even a single medication that is not clearly indicated.
-
Tamoxifen and CYP2D6 inhibitors, FDA Actions, and FDA Warnings.
